Literature DB >> 16570325

Factorial structure of a short version of the Center for Epidemiologic Studies Depression Scale.

Sheung-Tak Cheng1, Alfred C M Chan, Helene H Fung.   

Abstract

OBJECTIVE: To investigate the factor structure of a ten-item version of the Center for Epidemiologic Studies Depression Scale (CESD-10).
METHOD: Two hundred and thirty-one Chinese persons aged 60-92 were individually interviewed with the CESD-10. The data were subject to confirmatory factor analysis testing several competing models. The one-factor model hypothesizes that all ten items are loaded on a single factor. In the two-factor model, positive affect items are loaded on one factor, and the remaining items on the other. The three-factor model distinguishes between positive affect, depressed affect, and somatic symptoms.
RESULTS: The three-factor model was the best fitting model, with a comparative fit index of 0.95 and a standardized root mean square residual of 0.06. Depressed affect and somatic symptoms were highly correlated, and both were moderately correlated with positive affect. Nonetheless, all three factors appeared to tap a common underlying construct of depression-when a higher-order construct of depression was allowed to explain the intercorrelations of the three factors, depressed affect loaded at 0.88, somatic symptoms loaded at 0.92, and positive affect loaded at 0.51, on the higher-order construct.
CONCLUSION: The data provided support for the factorial validity of the CESD-10. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16570325     DOI: 10.1002/gps.1467

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  19 in total

1.  Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Authors:  Grant N Colfax; Glenn-Milo Santos; Moupali Das; Deirdre McDermott Santos; Tim Matheson; James Gasper; Steve Shoptaw; Eric Vittinghoff
Journal:  Arch Gen Psychiatry       Date:  2011-11

2.  Psychometric evaluation of a self-report scale to measure adolescent depression: the CESDR-10 in two national adolescent samples in the United States.

Authors:  Emily E Haroz; Michele L Ybarra; William W Eaton
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

3.  Cumulative socio-demographic risk factors and sleep outcomes in early childhood.

Authors:  Ariel A Williamson; Jodi A Mindell
Journal:  Sleep       Date:  2020-03-12       Impact factor: 5.849

4.  Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.

Authors:  Phillip O Coffin; Glenn-Milo Santos; Jaclyn Hern; Eric Vittinghoff; Deirdre Santos; Tim Matheson; Grant Colfax; Steven L Batki
Journal:  Addiction       Date:  2017-08-29       Impact factor: 6.526

5.  Maltreatment subtypes, depressed mood, and anhedonia: A longitudinal study with adolescents.

Authors:  Joseph R Cohen; Shiesha L McNeil; Ryan C Shorey; Jeff R Temple
Journal:  Psychol Trauma       Date:  2018-12-27

6.  Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco.

Authors:  Caitlin M Turner; Phillip Coffin; Deirdre Santos; Shannon Huffaker; Tim Matheson; Jason Euren; Anna DeMartini; Chris Rowe; Steven Batki; Glenn-Milo Santos
Journal:  J Subst Abuse Treat       Date:  2017-01-25

7.  Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults.

Authors:  Mohammadreza Mohebbi; Van Nguyen; John J McNeil; Robyn L Woods; Mark R Nelson; Raj C Shah; Elsdon Storey; Anne M Murray; Christopher M Reid; Brenda Kirpach; Rory Wolfe; Jessica E Lockery; Michael Berk
Journal:  Gen Hosp Psychiatry       Date:  2017-08-18       Impact factor: 3.238

8.  Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.

Authors:  Dagmar Amtmann; Jiseon Kim; Hyewon Chung; Alyssa M Bamer; Robert L Askew; Salene Wu; Karon F Cook; Kurt L Johnson
Journal:  Rehabil Psychol       Date:  2014-03-24

9.  Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

Authors:  Phillip Oliver Coffin; Glenn-Milo Santos; Moupali Das; Deirdre M Santos; Shannon Huffaker; Tim Matheson; James Gasper; Eric Vittinghoff; Grant N Colfax
Journal:  Addiction       Date:  2013-01-03       Impact factor: 6.526

10.  Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.

Authors:  Phillip O Coffin; Glenn-Milo Santos; Jaclyn Hern; Eric Vittinghoff; John E Walker; Tim Matheson; Deirdre Santos; Grant Colfax; Steven L Batki
Journal:  JAMA Psychiatry       Date:  2020-03-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.